In the present study, we found that diabetes has additional effects on FGF21 levels in CKD patients, which are supported by the fact that plasma FGF21 levels in CKD individuals with DM were significantly higher than those CKD patients without this complication (Figure 1B). Here, FGF21 is linked to diabetes mellitus.